https://memantineantagonist.co....m/observational-stud
Nonetheless, the epigenomic popular features of GIS-NEC remain unexplored. In this research, we have explained the epigenomic landscape of GIS-NEC and tiny cell lung carcinoma (SCLC) by integrating motif enrichment analysis through the assay of transposase-accessible chromatin sequencing (ATAC-seq) and enhancer profiling from a novel cleavage under objectives and tagmentation (CUTTag) assay for H3K27ac and identified ELF3 as one of the super-enhancer-related